Cellebrite DI (CLBT) Shares Outstanding (Diluted Average) (2020 - 2025)

Cellebrite DI (CLBT) has reported Shares Outstanding (Diluted Average) for 6 consecutive years, with $249.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) rose 19.3% year-over-year to $249.9 million; the TTM figure through Dec 2025 stood at $249.9 million (up 19.3% YoY), while the FY2025 annual figure was $249.9 million, up 19.3% from the prior year.
• Shares Outstanding (Diluted Average) came in at $249.9 million for Q4 2025 at Cellebrite DI, up from $209.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $249.9 million in Q4 2025, with the low at $360.0 in Q1 2024.
• Average Shares Outstanding (Diluted Average) over 5 years is $171.7 million, with a median of $195.6 million recorded in 2022.
• Across the five-year window, Shares Outstanding (Diluted Average) surged 60.84% in 2021 and slumped 100.0% in 2024, its largest moves.
• Year by year, Shares Outstanding (Diluted Average) stood at $199.1 million in 2021, then dropped by 2.07% to $195.0 million in 2022, then advanced by 2.49% to $199.8 million in 2023, then climbed by 4.83% to $209.5 million in 2024, then increased by 19.3% to $249.9 million in 2025.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $249.9 million, $209.5 million, and $360.0 for Q4 2025, Q4 2024, and Q1 2024 respectively.